Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum ; volume:17 ; number:1 ; day:12 ; month:12 ; year:2022 ; pages:1-14 ; date:12.2022
Molecular neurodegeneration ; 17, Heft 1 (12.12.2022), 1-14, 12.2022
- Creator
-
Gobom, Johan
Benedet, Andréa L.
Mattsson-Carlgren, Niklas
Montoliu-Gaya, Laia
Schultz, Nina
Ashton, Nicholas J.
Janelidze, Shorena
Servaes, Stijn
Sauer, Mathias
Pascoal, Tharick A.
Karikari, Thomas K.
Lantero-Rodriguez, Juan
Brinkmalm, Gunnar
Zetterberg, Henrik
Hansson, Oskar
Rosa-Neto, Pedro
Blennow, Kaj
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-022-00586-0
- URN
-
urn:nbn:de:101:1-2023022121255028099729
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gobom, Johan
- Benedet, Andréa L.
- Mattsson-Carlgren, Niklas
- Montoliu-Gaya, Laia
- Schultz, Nina
- Ashton, Nicholas J.
- Janelidze, Shorena
- Servaes, Stijn
- Sauer, Mathias
- Pascoal, Tharick A.
- Karikari, Thomas K.
- Lantero-Rodriguez, Juan
- Brinkmalm, Gunnar
- Zetterberg, Henrik
- Hansson, Oskar
- Rosa-Neto, Pedro
- Blennow, Kaj
- SpringerLink (Online service)
Other Objects (12)
Fluid biomarkers in Alzheimer’s disease – current concepts
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App NL−F/NL−F knock-in mouse model of Alzheimer’s disease
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App NL−F/NL−F knock-in mouse model of Alzheimer’s disease
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App NL−F/NL−F knock-in mouse model of Alzheimer’s disease
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease